Results of Breakthrough Research Trial Support Effectiveness of Glucosamine, Chondroitin in Treating Pain From Osteoarthritis
15 11월 2005 - 4:00AM
PR Newswire (US)
Study From National Institutes of Health Supports Use of
Glucosamine and Chondroitin, as Found in Move Free(R) Joint Care
Products, to Treat Moderate to Severe Pain SALT LAKE CITY, Nov. 14
/PRNewswire-FirstCall/ -- The natural supplements industry received
significant news today when the National Institutes of Health (NIH)
released the results of its highly anticipated
Glucosamine/Chondroitin Arthritis Intervention Trial (GAIT)
involving the use of the nutrients glucosamine and/or chondroitin
by individuals experiencing pain from osteoarthritis. Presented at
the American College of Rheumatology (ACR) Annual Scientific
Meeting in San Diego, the study demonstrates strong support for the
use of a combination of glucosamine and chondroitin by
osteoarthritis patients to relieve moderate to severe pain. "As a
pioneer in the glucosamine/chondroitin category, we are thrilled
with the results of this large-scale study," said Dr. Luke R.
Bucci, vice president of research at Schiff Nutrition
International. "The findings further support the growing scientific
literature demonstrating the benefits of natural supplements such
as glucosamine and chondroitin in promoting joint health -- and
that's great news for those who suffer from osteoarthritis." The
five-year study, sponsored by the NIH, assessed the effectiveness
and safety of glucosamine and chondroitin -- either used alone or
combined. The study concluded that a combination of glucosamine and
chondroitin was proven to be even more effective than prescription
pain medication in treating moderate to severe knee pain due to
osteoarthritis. These findings were mirrored by the results from a
second study, the European-based Glucosamine Unum in Die Efficacy
(GUIDE) Trial, which was also presented at the ACR's Annual
Scientific Meeting. The results of the GUIDE Trial concluded that
glucosamine sulfate (1,500 mg/day) was more effective than
acetaminophen (3,000 mg/day) on various pain and mobility indices
of osteoarthritis. Healthy cartilage -- the smooth, elastic padding
that covers the ends of bones -- absorbs energy from the shock of
physical movement, and allows bones to glide over one another.
Osteoarthritis occurs when cartilage wears away due to natural
aging, sports injuries or repetitive motion -- allowing bones to
rub together, causing pain, swelling and loss of motion in the
joint. Osteoarthritis affects more than 21 million Americans. The
glucosamine/chondroitin blend in Schiff's Move Free(R) products --
the same nutrients used by the NIH in its trial -- is designed to
support joint cartilage and maintain healthy joint function.
Glucosamine, a natural amino sugar produced by the body, plays an
important role in providing the stimulus for building healthy
cartilage. Chondroitin, a naturally occurring nutrient in the
connective tissue, attracts water to the area, and it makes the
cartilage more elastic and better able to absorb shock. In
addition, Move Free products also contain Joint Fluid (hyaluronic
acid), a component of synovial fluid -- the natural lubrication
that allows joints to glide easily and smoothly over one another.
Importantly, a recent independent study showed that a blend of
glucosamine/chondroitin with the addition of Joint Fluid was more
effective in providing joint comfort than glucosamine/chondroitin
alone. The best selling Move Free joint care line includes Move
Free(R) Double Strength, Move Free(R) Triple Strength and Move
Free(R) Plus MSM. Move Free products are available at club stores,
mass merchandisers, grocery stores, pharmacies, health food and
drug stores nationwide. About Schiff Nutrition International Schiff
Nutrition International, Inc. (NYSE:WNI), a leader in the dietary
supplement industry since its beginnings 65 years ago, is one of
the most trusted and respected brands due to its focus on research,
innovations and delivery of high quality supplements. A pioneer in
the glucosamine/chondroitin category, Schiff is the maker of the
best selling Move Free(R) joint care supplements. Schiff emphasizes
the use of the finest natural ingredients to ensure that its
products meet strict standards for labeled potency, purity and
stability. Based in Salt Lake City, Schiff develops, manufactures,
markets and sells branded and private label vitamins and
nutritional supplements in the United States and throughout the
world. For more information, consumers may call 1-800-526-6251 or
visit http://www.schiffvitamins.com/. MEDIA CONTACTS: Max Martens
or Danielle Clark Porter Novelli, (310) 444-7000 DATASOURCE: Schiff
Nutrition International, Inc. CONTACT: Max Martens or Danielle
Clark, both of Porter Novelli, +1-310-444-7000, for Schiff
Nutrition International, Inc. Web site:
http://www.schiffvitamins.com/
Copyright
Schiff Nutrit (NYSE:WNI)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024
Schiff Nutrit (NYSE:WNI)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024
Schiff Nutrition International, Inc. (뉴욕 증권거래소)의 실시간 뉴스: 최근 기사 0
More Weider Nutrit Intl News Articles